<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30349393</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1179-1349</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>10</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Clinical epidemiology</Title>                <ISOAbbreviation>Clin Epidemiol</ISOAbbreviation>            </Journal>            <ArticleTitle>Familial risks of second primary cancers and mortality in ovarian cancer patients.</ArticleTitle>            <Pagination>                <MedlinePgn>1457-1466</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.2147/CLEP.S174173</ELocationID>            <Abstract>                <AbstractText Label="Background" NlmCategory="UNASSIGNED">With improving survival in ovarian cancer, second primary cancers (SPCs) and their etiological foundations are becoming an issue. The ways in which family history may influence the occurrence of SPCs and the related mortality are not well known.</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Based on the Swedish Family-Cancer Database, we identified 11,300 ovarian cancer patients and followed them for diagnoses of SPCs until the end of 2015. Relative risks (RRs) of SPC in patients who had parents or siblings diagnosed with the same cancer (positive family history) were compared to those in patients without a family history (negative family history). Causes of death were compared between patients with and without SPC.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">A total of 1,111 (9.8%) ovarian cancer patients developed SPC with a median follow-up of 8 years. The impact of a family history of cancer on the risk of the same cancer as SPC was significant for colon (RR<sub>positive family history</sub> [95% CI] vs RR<sub>negative family history</sub> [95% CI]: 4.95 [3.03-8.09] vs 2.00 [1.63-2.47]), lung (3.32 [1.88-5.84] vs 1.45 [1.16-1.83]), and breast (2.08 [1.58-2.73] vs 1.01 [0.88-1.15]) cancers. With a family history of any cancer, the RR for non-ovarian SPCs was 1.66 (1.54-1.74), in contrast to 1.38 (1.24-1.54) for SPCs without any family history (<i>P</i>-trend &lt;0.001). Accounting for 42.1% of all deaths, SPC was found to be the main cause of death for patients with SPC.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">A family history of a particular cancer contributed to an increased risk of SPC at the same site. Therefore, considering family history at the time of diagnosis of ovarian cancer may alert physicians to a syndromic background, management of which may help the patient and her family members.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Zheng</LastName>                    <ForeName>Guoqiao</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Faculty of Medicine, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chattopadhyay</LastName>                    <ForeName>Subhayan</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Faculty of Medicine, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Försti</LastName>                    <ForeName>Asta</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Primary Health Care Research, Lund University, 205 02 Malmö, Skåne County, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sundquist</LastName>                    <ForeName>Kristina</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Primary Health Care Research, Lund University, 205 02 Malmö, Skåne County, Sweden.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Family Medicine and Community Health.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Community-Based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Izumo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hemminki</LastName>                    <ForeName>Kari</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany, g.zheng@dkfz.de.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Primary Health Care Research, Lund University, 205 02 Malmö, Skåne County, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>11</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>New Zealand</Country>            <MedlineTA>Clin Epidemiol</MedlineTA>            <NlmUniqueID>101531700</NlmUniqueID>            <ISSNLinking>1179-1349</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2016 Jul 15;6:29765</RefSource>                <PMID Version="1">27416752</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2013 May;10(5):289-301</RefSource>                <PMID Version="1">23529000</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Fam Cancer. 2008;7(2):163-72</RefSource>                <PMID Version="1">17939062</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lung Cancer. 2014 Oct;86(1):78-84</RefSource>                <PMID Version="1">25130083</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2012 Jul;23(7):1854-63</RefSource>                <PMID Version="1">22115926</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2004 Apr 1;10(7):2473-81</RefSource>                <PMID Version="1">15073127</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2017 May 10;35(14):1584-1590</RefSource>                <PMID Version="1">28384078</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2003 May 15;97(10):2432-9</RefSource>                <PMID Version="1">12733142</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Epidemiol. 2009 Nov;62(11):1202-9</RefSource>                <PMID Version="1">19364635</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Oncol. 2018 Apr;57(4):440-455</RefSource>                <PMID Version="1">29226751</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Rep. 2016 Nov;36(5):2823-2835</RefSource>                <PMID Version="1">27601186</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2015 Dec 24;373(26):2499-511</RefSource>                <PMID Version="1">26699166</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2001 Aug;82(2):223-8</RefSource>                <PMID Version="1">11531271</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2014 Jun 14;14:439</RefSource>                <PMID Version="1">24929562</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2012 Nov 1;131(9):2085-93</RefSource>                <PMID Version="1">22307919</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Oncol. 1997;36(5):465-9</RefSource>                <PMID Version="1">9292741</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2016 Oct;122(19):3075-86</RefSource>                <PMID Version="1">27377470</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2005 Dec 15;104(12):2807-16</RefSource>                <PMID Version="1">16284991</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>ESMO Open. 2017 May 2;2(2):e000172</RefSource>                <PMID Version="1">28761745</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2012 Oct 20;30(30):3734-45</RefSource>                <PMID Version="1">23008293</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2017 Sep 1;109(9):</RefSource>                <PMID Version="1">28376154</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gastroenterology. 2005 Dec;129(6):1889-99</RefSource>                <PMID Version="1">16344057</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genet Med. 2015 Jan;17(1):24-6</RefSource>                <PMID Version="1">25375653</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2013 Jul;49(10):2403-10</RefSource>                <PMID Version="1">23518210</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Epidemiol. 2017 Sep;32(9):765-773</RefSource>                <PMID Version="1">28983736</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2012 Mar;23(3):604-10</RefSource>                <PMID Version="1">21586686</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2012 Oct;23(10):2720-4</RefSource>                <PMID Version="1">22473595</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2011 Jun 8;305(22):2304-10</RefSource>                <PMID Version="1">21642682</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2006 May;101(2):238-43</RefSource>                <PMID Version="1">16360201</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Fam Cancer. 2012 Jun;11(2):235-42</RefSource>                <PMID Version="1">22187320</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2017 Apr 1;140(7):1510-1516</RefSource>                <PMID Version="1">28006863</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2005 Feb;16(2):322-9</RefSource>                <PMID Version="1">15668291</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">cause of death</Keyword>            <Keyword MajorTopicYN="N">cumulative incidence</Keyword>            <Keyword MajorTopicYN="N">familial cancer</Keyword>            <Keyword MajorTopicYN="N">second primary cancer</Keyword>        </KeywordList>        <CoiStatement>Author contributions KH proposed the research conception and study design. KS, KH, GZ, and SC contributed to the collection and assembly of data. GZ, KH, SC, and AF were responsible for the data analysis and interpretation. KH completed the draft of the manuscript, and all the authors revised it critically for important intellectual content. The final manuscript was reviewed and approved by all authors. All authors are accountable for all aspects of the work. Disclosure The authors report no conflicts of interest in this work.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30349393</ArticleId>            <ArticleId IdType="doi">10.2147/CLEP.S174173</ArticleId>            <ArticleId IdType="pii">clep-10-1457</ArticleId>            <ArticleId IdType="pmc">PMC6188204</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>